Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors

Clinical trial NCT07482592 · RECRUITING

Trial details

NCT number: NCT07482592
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Cancer

Start date: 2026-04-15
Primary completion: 2027-12-01
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.